Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it has certain limitations, especially when it comes to intermediate lesions or coronary dissections.  

¿Debemos comenzar a usar OCT en los IAM sin lesiones obstructivas?

Using imaging, especially high resolution such as OCT, has been looked into by some studies, but never randomized studies. 

The EROSION III is a randomized controlled study on patients with ST elevation MI who after guidewire lesion crossing should present a non-obstructive lesion (≤70%) and TIMI flow III. Predilation was excluded, but thrombus aspiration was allowed, when necessary. 

The study looked at 226 patients, 112 guided by OCT and 114 by angiography.

There were no differences between populations: mean age was 55, 80% were men, 21% were diabetic. Thrombus aspiration was done in 93% of patients and obstruction rate was 54%.

Read also: Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

OCT patients saw 66% plaque rupture, 26% plaque erosion, 4.5% calcified nodules, 0.9% intimal fissure and 2.7% no evidence of obstruction or atherosclerotic lesion. 

Anterior descending infarction was more frequent in the OCT group. Also, this population presented longer procedural time.  

The OCT group saw 15% reduction in stent implantation (43.8% vs 53.8% p=0.024) and residual lesions (4.6% vs 8.7% p<0.001).

Read also: Hypertrophic Cardiomyopathy: Analyzing a Historical Series.

After one year, there were no differences in death, stroke, MI, TLR, malign arrythmia, rehospitalization for unstable angina or cardiac failure. 

Conclusion

In patients with ST elevation MI, OCT guided reperfusión compared against angiography guided reperfusión was associated with lower stent implantation rate at primary PCI. These favorable results indicate the value of OCT imaging guided reperfusión in patients with ST elevation MI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, et al. J Am Coll Cardiol Intv 2022;15:846–856.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...